Lexicon Pharmaceuticals reported 12.44 in PE Price to Earnings for its fiscal quarter ending in June of 2021.





Pe Change Date
Abbott 34.85 10.99 Sep/2026
Acadia Pharmaceuticals 9.52 1.81 Sep/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Eli Lilly 64.5 31.61 Sep/2026
Halozyme Therapeutics 16.12 3.61 Sep/2026
Illumina 70.8 21.82 Sep/2026
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 25.86 3.57 Sep/2026
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
MannKind 201.15 102.55 Mar/2026
Merck 34.36 2.11 Sep/2026
Moderna 27.22 14.51 Jun/2023
Novartis 19.17 3.24 Sep/2026
PTC Therapeutics 8.76 0 Jun/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics 32.09 22.66 Sep/2026
Thermo Fisher Scientific 35.46 9.05 Sep/2026
United Therapeutics 19.41 0.26 Sep/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023